New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study

AIM: Recently, the neo‐Glasgow prognostic score (GPS), a composite biomarker determined by the C‐reactive protein level and albumin–bilirubin grade, was developed to predict outcomes in hepatocellular carcinoma (HCC) patients who undergo hepatic resection. The present research investigated whether t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Toshifumi, Kumada, Takashi, Hiraoka, Atsushi, Kariyama, Kazuya, Tani, Joji, Hirooka, Masashi, Takaguchi, Koichi, Atsukawa, Masanori, Fukunishi, Shinya, Itobayashi, Ei, Tsuji, Kunihiko, Tajiri, Kazuto, Ochi, Hironori, Ishikawa, Toru, Yasuda, Satoshi, Ogawa, Chikara, Toyoda, Hidenori, Hatanaka, Takeshi, Nishimura, Takashi, Kakizaki, Satoru, Kawata, Kazuhito, Shimada, Noritomo, Tada, Fujimasa, Nouso, Kazuhiro, Tsutsui, Akemi, Ohama, Hideko, Morishita, Asahiro, Nagano, Takuya, Itokawa, Norio, Okubo, Tomomi, Arai, Taeang, Kosaka, Hisashi, Imai, Michitaka, Naganuma, Atsushi, Nakamura, Shinichiro, Koizumi, Yohei, Kaibori, Masaki, Iijima, Hiroko, Hiasa, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067064/
https://www.ncbi.nlm.nih.gov/pubmed/36484470
http://dx.doi.org/10.1002/cam4.5495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067064/
https://www.ncbi.nlm.nih.gov/pubmed/36484470
http://dx.doi.org/10.1002/cam4.5495

Ejemplares similares